AusBiotech

IP Australia has published a response to its consultation on draft legislation that includes measures to implement aspects of the Government’s response to the Productivity Commission’s (PC) inquiry into Australia’s IP arrangements.

AusBiotech has made a submission into a Senate Inquiry into the legislative Bill that includes the R&D Tax incentive (RDTI) reforms, urging the Inquiry to delay its passage until the impacts are better understood and can be mitigated.

AusBiotech has extended its alliance with MTPConnect, the Growth Centre for Australia’s medical technology, biotechnology and pharmaceutical sector, by signing a new Memorandum of Understanding (MoU) to collaborate.

The AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards were announced yesterday at the AusBiotech 2018 national conference in Brisbane.

AusBiotech has today kicked off the biggest week of the year for biotech with the opening of its annual Biotech Invest and Partnering event in Melbourne, to be followed tomorrow by its national conference, AusBiotech 2018, in Brisbane.

In support of the largest medical technology industry in Australia, the NSW Departments of Industry and Health have recently launched the NSW Medical Technology Industry Development Strategy 2018 to promote further growth and innovation in the industry.

AusBiotech welcomes a Senate Inquiry for the Bill seeking to seriously reduce the R&D Tax Incentive (RDTI), after calling on the Government to delay the passage of the RDTI reform legislation until the details, mechanics and impacts are better understood and can be mitigated.

AusBiotech has released its 2018-21 strategic plan, with a focus on member engagement, advocacy, ensuring a sustainable organisation, strengthening its relevance and reputation, and building the sector.

AusBiotech is pleased to present the Annual Report for the period 1 July 2017 – 30 June 2018, showing a year of delivery, achievement and evolution.

The annual AusBiotech conference, which brings together Australian and international biotech leaders and stakeholders, will return to Brisbane this month, creating a leaders’ forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally.

It is anticipated that the impact of South Australia remaining GM-free will be addressed with two reviews currently underway into the South Australian (SA) GM moratorium; one by government and one by an independent reviewer.

The Victorian state election, slated for 24 November 2018, has prompted 11 organisations, including AusBiotech, to make a joint statement calling on all contesting parties to adopt positions that...